Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Jun 5, 2025; 16(2): 105375
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105375
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105375
Figure 1 Schematic representation of the interplay between gut microbiome, iron metabolism, and systemic inflammation in anemia.
Figure 2 Diagram illustrating microbiome-targeted interventions, including probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation.
GOS: Galactooligosaccharide; FOS: Fructooligosaccharide; SCFA: Short-chain fatty acid.
Figure 3 Comparison of microbiota composition in healthy vs anemic cancer patients.
IL: Interleukin; SCFA: Short-chain fatty acid; TNF: Tumor necrosis factor-alpha.
Figure 4 Role of dietary intervention in attaining a healthy gut microbiome.
DASH: Dietary approaches to stop hypertension; MIND diet: Combines mediterranean and DASH diets.
Figure 5 Dysbiosis-induced immune dysregulation.
Figure 6 Gut microbiome in colon cancer.
- Citation: Bangolo A, Amoozgar B, Habibi M, Simms E, Nagesh VK, Wadhwani S, Wadhwani N, Auda A, Elias D, Mansour C, Abbott R, Jebara N, Zhang L, Gill S, Ahmed K, Ip A, Goy A, Cho C. Exploring the gut microbiome’s influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies. World J Gastrointest Pharmacol Ther 2025; 16(2): 105375
- URL: https://www.wjgnet.com/2150-5349/full/v16/i2/105375.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i2.105375